225 related articles for article (PubMed ID: 35429118)
1. Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.
Wang L; Shannar AAF; Wu R; Chou P; Sarwar MS; Kuo HC; Peter RM; Wang Y; Su X; Kong AN
Mol Nutr Food Res; 2022 Jun; 66(12):e2200028. PubMed ID: 35429118
[TBL] [Abstract][Full Text] [Related]
2. Nfe2l2 Regulates Metabolic Rewiring and Epigenetic Reprogramming in Mediating Cancer Protective Effect by Fucoxanthin.
Wang L; Wu R; Sargsyan D; Su S; Kuo HC; Li S; Chou P; Sarwar MS; Phadnis A; Wang Y; Su X; Kong AN
AAPS J; 2022 Jan; 24(1):30. PubMed ID: 35043283
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic modification of Nrf2 in 5-fluorouracil-resistant colon cancer cells: involvement of TET-dependent DNA demethylation.
Kang KA; Piao MJ; Kim KC; Kang HK; Chang WY; Park IC; Keum YS; Surh YJ; Hyun JW
Cell Death Dis; 2014 Apr; 5(4):e1183. PubMed ID: 24743738
[TBL] [Abstract][Full Text] [Related]
5. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
Li S; Wu R; Wang L; Dina Kuo HC; Sargsyan D; Zheng X; Wang Y; Su X; Kong AN
Mol Carcinog; 2022 Jan; 61(1):111-121. PubMed ID: 34727410
[TBL] [Abstract][Full Text] [Related]
6. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
[TBL] [Abstract][Full Text] [Related]
7. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.
Zuo Q; Wu R; Xiao X; Yang C; Yang Y; Wang C; Lin L; Kong AN
J Cell Biochem; 2018 Nov; 119(11):9573-9582. PubMed ID: 30129150
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics Reactivation of Nrf2 in Prostate TRAMP C1 Cells by Curcumin Analogue FN1.
Li W; Pung D; Su ZY; Guo Y; Zhang C; Yang AY; Zheng X; Du ZY; Zhang K; Kong AN
Chem Res Toxicol; 2016 Apr; 29(4):694-703. PubMed ID: 26991801
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
Camiña N; Penning TM
Br J Cancer; 2022 May; 126(9):1244-1252. PubMed ID: 34845361
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.
Saldanha SN; Kala R; Tollefsbol TO
Exp Cell Res; 2014 May; 324(1):40-53. PubMed ID: 24518414
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
13. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
[TBL] [Abstract][Full Text] [Related]
15. Sodium butyrate protects against high-fat diet-induced oxidative stress in rat liver by promoting expression of nuclear factor E2-related factor 2.
Sun B; Jia Y; Yang S; Zhao N; Hu Y; Hong J; Gao S; Zhao R
Br J Nutr; 2019 Aug; 122(4):400-410. PubMed ID: 31204637
[TBL] [Abstract][Full Text] [Related]
16. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
[TBL] [Abstract][Full Text] [Related]
18. Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells.
Chou PJ; Sarwar MS; Wang L; Wu R; Li S; Hudlikar RR; Wang Y; Su X; Kong AN
Cancer Prev Res (Phila); 2023 Jun; 16(6):321-332. PubMed ID: 36867722
[TBL] [Abstract][Full Text] [Related]
19. Interaction of DNA demethylase and histone methyltransferase upregulates Nrf2 in 5-fluorouracil-resistant colon cancer cells.
Kang KA; Piao MJ; Ryu YS; Kang HK; Chang WY; Keum YS; Hyun JW
Oncotarget; 2016 Jun; 7(26):40594-40620. PubMed ID: 27259240
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic modifications of triterpenoid ursolic acid in activating Nrf2 and blocking cellular transformation of mouse epidermal cells.
Kim H; Ramirez CN; Su ZY; Kong AN
J Nutr Biochem; 2016 Jul; 33():54-62. PubMed ID: 27260468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
